Authors: Aerssens, J Raeymaekers, P Lilienfeld, S Geerts, H Konings, F Parys, W

Citation: J. Aerssens et al., APOE genotype: No influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease, DEMENT G C, 12(2), 2001, pp. 69-77

Authors: Lilienfeld, S Parys, W

Citation: S. Lilienfeld et W. Parys, Galantamine: Additional benefits to patients with Alzheimer's disease, DEMENT G C, 11, 2000, pp. 19-27

Authors: Wilcock, GK Lilienfeld, S Gaens, E

Citation: Gk. Wilcock et al., Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial, BR MED J, 321(7274), 2000, pp. 1445-1449

Authors: Tariot, PN Solomon, PR Morris, JC Kershaw, P Lilienfeld, S Ding, C

Citation: Pn. Tariot et al., A 5-month, randomized, placebo-controlled trial of galantamine in AD, NEUROLOGY, 54(12), 2000, pp. 2269-2276

Authors: Sandoval, AMR Hancock, D Poythress, N Edens, JF Lilienfeld, S

Citation: Amr. Sandoval et al., Construct validity of the psychopathic personality inventory in a correctional sample, J PERS ASSE, 74(2), 2000, pp. 262-281